Drug Development & Delivery has more than 26,000 digital and print subscribers, linking technology and service providers with R&D scientists and managers, business development experts, and corporate professionals working in pharmaceutical and biotech firms around the world. The website has an average of 46,000 monthly visitors.
Drug Development & Delivery recently spoke with Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems at Stevanato Group, about their joint effort to produce the innovative Aidaptus auto-injector.
See the complete Executive Interview below